Nasym

RSS

bovine respiratory syncytial virus vaccine (live)

Authorised
This medicine is authorised for use in the European Union.

Overview

Nasym is a vaccine used to protect cattle against bovine respiratory syncytial virus, a disease that affects their airways. Nasym reduces shedding of virus and respiratory signs such as raised breathing rate, difficulty breathing, watery eyes and runny nose. Nasym contains bovine respiratory syncytial virus strain Lym-56.

This EPAR was last updated on 05/03/2020

Authorisation details

Product details
Name
Nasym
Agency product number
EMEA/V/C/004897
Active substance
live attenuated bovine respiratory syncytial virus (BRSV), strain Lym-56
International non-proprietary name (INN) or common name
bovine respiratory syncytial virus vaccine (live)
Species
Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI02AD04
Publication details
Marketing-authorisation holder
Laboratorios Hipra S.A.
Revision
1
Date of issue of marketing authorisation valid throughout the European Union
29/07/2019
Contact address

Avda. La Selva, 135
17170- Amer (Girona)
Spain

Product information

26/02/2020 Nasym - EMEA/V/C/004897 - IB/0001

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Immunologicals for bovidae
  • Cattle

  • Live viral vaccines
  • bovine respiratory syncytial virus (BRSV)

Therapeutic indication

Active immunisation of cattle to reduce virus shedding and respiratory clinical signs caused by bovine respiratory syncytial virus infection.

Assessment history

How useful was this page?

Add your rating
Average
1 rating